Escitalopram for Agitation in Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary and Foothills Medical Centre
Calgary, Alberta, Canada
- Lawson Health Research Institute/parkwood Institute
London, Ontario, Canada
- Centre for Addiction and Mental Health
Toronto, Ontario, Canada
- Centre for Memory and Aging
Toronto, Ontario, Canada
- Neuropsychopharmacology Research Group, Sunnybrook
Toronto, Ontario, Canada
- Unity Health
Toronto, Ontario, Canada
- Ontario Shores
Whitby, Ontario, Canada
- Banner Sun Health Research Institute
Sun City, Arizona, United States
- Biomedical Research Foundation
Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- University of California Los Angeles/va Greater Los Angeles Healthcare System
Los Angeles, California, United States
- University of Southern California Keck School of Medicine Memory and Aging Center
Los Angeles, California, United States
- Miami Jewish Health Systems
Miami, Florida, United States
- Kansas School of Medicine-Wichita Center for Clinical Research
Wichita, Kansas, United States
- Johns Hopkins University School of Medicine, Bayview Medical Center
Baltimore, Maryland, United States
- Maryland Va Health Care System
Baltimore, Maryland, United States
- Alzheimer Disease Center
Quincy, Massachusetts, United States
- Hackensack Meridian Health
Hackensack, New Jersey, United States
- Columbia University
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Ohio State University
Columbus, Ohio, United States
- Abington Neurological Associates, Ltd
Abington, Pennsylvania, United States
- Alzheimer Disease Research Center; University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Roper St. Francis Healthcare
Charleston, South Carolina, United States
- Baylor at&t Memory Center
Dallas, Texas, United States
- Ut Health San Antonio
San Antonio, Texas, United States
- University of Virginia Adult Neurology
Charlottesville, Virginia, United States
- Eastern Virginia Medical School
Norfolk, Virginia, United States
- Northwest Clinical Research Center
Bellevue, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jan 2018
- Primary completion
- 5 Apr 2024
- Completion
- 31 May 2025
- Last update posted
- 31 Jan 2025
- Registered enrollment
- 187
- Registry id
- NCT03108846
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.